This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Kristin P O'Grady: Innovator in Reactive Oxygen Species-Responsive Compositions
Introduction
Kristin P O'Grady is a notable inventor based in Nashville, TN. She has made significant contributions to the field of pharmaceutical compositions, particularly focusing on reactive oxygen species (ROS). Her innovative work has led to the development of a unique emulsion that targets elevated levels of reactive oxygen species.
Latest Patents
Kristin holds 1 patent for her invention titled "Reactive oxygen species (ROS)-responsive compositions and methods thereof." This patent describes a reactive oxygen species savaging emulsion that includes an injectable pharmaceutically acceptable composition and a polymeric poly(propylene sulfide) microsphere. The design allows for targeted delivery to sites with elevated reactive oxygen species, and the microsphere can be loaded with a biologically active agent.
Career Highlights
Kristin is affiliated with Vanderbilt University, where she continues her research and development in innovative pharmaceutical solutions. Her work is instrumental in advancing the understanding and application of reactive oxygen species in medical treatments.
Collaborations
Some of her notable coworkers include Craig L Duvall and John R Martin, who contribute to her research endeavors and collaborative projects.
Conclusion
Kristin P O'Grady's contributions to the field of reactive oxygen species-responsive compositions highlight her innovative spirit and dedication to advancing medical science. Her work at Vanderbilt University continues to pave the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
